Bailey Glasser client Phillip Dressel and Mass Torts Practice Group Leader David L. Selby are featured in the The Wall Street Journal: “The Cancer Victims Who Could Sink Bayer’s Roundup Settlement.” To read the full article, visit this gift link.

This article describes the current landscape of lawsuits involving Bayer’s Roundup weedkiller. On February 17, 2026 “Monsanto announced a proposed U.S. nationwide class settlement designed to resolve current and future Roundup™ claims alleging Non-Hodgkin Lymphoma (NHL) injuries through a long-terms claims program.” Under the terms of the proposed class settlement, claimants can choose whether they want to opt-out of the class settlement.

Bailey Glasser did not object to the class settlement and takes the position that the decision of whether claimants should participate in the class settlement or opt-out is a client centric decision and one which should be made by each individual client. Bailey Glasser is not opposed to the class settlement and acknowledges they will have clients that choose to participate in the class settlement and some that will not. Moreover, Bailey Glasser is not attempting to sink Bayer’s Roundup Settlement but simply opting out certain clients, including those cases already set for trial.

Mr. Dressel is one of the clients that has decided to not participate in the class settlement. Mr. Dressel is a landscaper who used Roundup. In 2023 he noticed lesions on his arms, and sometime thereafter was diagnosed with cancer. Since then, he has had many medical procedures, including having his left leg amputated and a tumor removed from his skull. Given his extensive pain and suffering, and shortened life expectancy, it is our position that Mr. Dressel cannot be adequately compensated under the existing terms of the class settlement. As noted in the WSJ article: David Selby II, one of the attorneys who represents Mr. Dressel, said we are “working to get him a trial as soon as possible.”

Bailey & Glasser is a national law firm leading litigation against companies like Monsanto.

Twelve Bailey Glasser partners were named to the 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers guide. Our 2026 recipients are John W. Barrett; Mark G. Boyko; Katherine E. Charonko; Brian A. Glasser; Joshua I. Hammack; James L. Kauffman; Lawrence “Larry” Lederer; Jonathan R. Marshall; D. Todd Mathews; Michael L. Murphy; Gregory Y. Porter; and David L. Selby II.

Lawdragon’s announcement states:

We’re honored to recognize The 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers.

These amazing advocates find pathways to justice for investors who have been defrauded, companies who have been blocked from fair competition and consumers who have been duped, hornswoggled and otherwise had their rights trampled on by ruthless corporations, from social media to pharmaceuticals.

This is our 9th edition reporting on leading lights of the plaintiff financial bar. This guide and the practices it represents have grown exponentially since 2007, when we first published a guide to plaintiff lawyers. Resumed in 2019, it reflects the astounding scale of wealth and, some would say, greed that permeates big business.

Year by year, the accomplishments of these lawyers astound in both the sheer size of the financial compensation they achieve and in the perseverance and legal skill required to succeed in these cases.

View the full 2026 Lawdragon 500 Leading Plaintiff Financial Lawyers announcement and list here.

Meet this year’s recipients at this link.

Bailey Glasser Mass Torts Practice Group Leader David L. Selby II was quoted in a Wall Street Journal article about the ongoing talc litigation with Johnson & Johnson and a Thursday ruling that the law firm of Beasley Allen was disqualified from representing talc plaintiffs moving forward. Beasley Allen will appeal.

David Selby commented that “[i]f the ruling were to stand, then all these women would have to seek new counsel,” he said. “It delays trials. It does nothing but work in favor of J&J.”

Read the article here.

Bailey Glasser ERISA Litigators Defeat Motion to Dismiss ESOP Case Against Members of Privacy Equity Firm

This decision is notable because it provides accountability for principals at private equity firms who may be personally liable for their conduct in orchestrating ESOP transactions.

Continue reading

Bailey Glasser’s ERISA Practice Group, along with co-counsel Nichols Kaster, recently defeated a Motion to Dismiss filed by company directors who also worked for the private equity firm that sold the company to the ESOP. The court’s decision made clear that principals at private equity firms cannot hide behind corporate formalities to avoid liability as ERISA fiduciaries when they orchestrate the sale of a company to an ESOP at far above fair market value.

The Bailey Glasser litigation team includes Gregory Porter, the group’s Practice Group Leader; partner Patrick Muench; and lawyer Laura Babiak.

This lawsuit was filed in 2022 by plaintiff Paul Laidig, along with other current and former employees of Vi-Jon, a company that manufactures personal care products, including hand sanitizer. The plaintiffs hold shares in the company through the Vi-Jon Employee Stock Ownership Plan (“ESOP”). Through a complicated set of transactions that began during COVID, the defendants caused the ESOP to purchase the company based on unrealistic projections, including that hand sanitizer sales, which peaked early during COVID, would not see a return to normal sales growth. Essentially, they foisted the company on the employees assuming close to peak COVID sales into perpetuity.

We allege that the defendants caused the ESOP to engage in a prohibited transaction in violation of Employee Retirement Income Security Act, 29 U.S.C. § 1001, et seq. (“ERISA”). Specifically, we allege that defendants orchestrated the ESOP transaction at an artificially inflated purchase price by capitalizing on overly optimistic performance expectations due to the temporary surge in demand for hand sanitizer during the COVID-19 pandemic, all because Berkshire had been unable to unload its stake in Vi-Jon for a high-enough price to exceed Berkshire’s compensation hurdle—i.e., the threshold rate at which managers and general partner entities receive a share of profits. We assert that the inflated price resulted in an unsustainable debt-load, which, in turn, has put Plaintiffs’ retirement benefits in jeopardy and caused pressure from lenders on management to make decisions that compromise the company’s value and long-term viability, among other things.

The Motion to Dismiss addressed, in part, individual director-defendants’ motions to dismiss, alleging that they were not fiduciaries and also did not have sufficient knowledge related to the ESOP transaction at issue. The United States District Court for the Northern District of Illinois disagreed, finding that the plaintiffs sufficiently alleged required fiduciary and legal duties. Indeed, related to individual defendants who sought to be dismissed from the case: “[t]rue, only the board of VJ Holding Corp. may have expressly approved GreatBanc’s engagement as trustee, but Plaintiffs allege that New Defendants all exercised control with respect to the ESOP transaction to a certain extent, by, for example, setting the transaction in motion, causing the selection of GreatBanc, monitoring and interacting with GreatBanc, and approving the transaction. Although a defendant’s mere status as a director or officer of a company does not necessarily make them a fiduciary, a defendant’s or group of defendants’ ability to control the appointment and approval of a trustee through their positions may support a reasonable inference regarding fiduciary status.”

This decision is especially important because it provides accountability for principals at private equity firms who may be personally liable for their conduct in orchestrating ESOP transactions.

The case will now proceed to discovery. To read the decision and learn more, visit this link.

The Legal 500 has named partners Brian A. Glasser, Nicholas S. Johnson, Cary Joshi, Elliott McGraw, Michael L. Murphy, and Gregory Y. Porter to its Washington D.C. Elite series for commercial disputes. Brian Glasser and Michael Murphy received its top Tier 1 ranking.

According to Legal 500, the U.S. Elite series emphasizes lawyers who are handling work at the top of the legal market in their respective cities. We appreciate the recognition and congratulate all lawyers on this list.

Learn more about the award and lawyers here.